Five Things Going Right: August 20, 2026

Five real advances in science, medicine, technology, and the environment, each verified against the original reporting. In this episode: A shigellosis vaccine candidate (WRSs2) showed 89% efficacy against Shigella sonnei in a trial published in; An international research team led by IPK Leibniz Institute published a high-quality reference genome; A new model simulates how solar panels can cool crops and reduce heat stress for workers in agrivoltaic; EMBL scientists discovered that phages use a single enzyme (T7 kinase) to shut down multiple bacterial; An injectable hydrogel platform allows drug-loaded nanocarriers to remain in joints for several weeks and. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.optimistdaily.com/2026/08/why-the-poo-taboo-has-held-back-a-killer-disease-and-whats-changing/ https://phys.org/news/2026-08-rye-genome-uncovers-diversity-wheat.html https://phys.org/news/2026-08-solar-panels-cool-crops-workers.html https://phys.org/news/2026-08-viral-loose-cannon-enzyme-phages.html https://scitechdaily.com/new-injectable-hydrogel-could-transform-osteoarthritis-treatment/